RIA Monitor

Disposition · Portfolio-company

Majority stake in STADA Arzneimittel AG

Transaction overview

Status: Announced

Announcement date:

Exact closing date not established.

Bain Capital and Cinven announced a definitive agreement to sell a majority stake in STADA Arzneimittel AG to CapVest Partners. Bain and Cinven intended to retain a minority stake after completion. The release expected completion in the first half of 2026 and did not establish a closing date.

Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.

Source evidence

  1. Bain Capital and Cinven to sell majority stake in STADA to CapVest ↗

    Cinven · Published Sep 1, 2025

    Bain Capital and Cinven announced a definitive agreement to sell a majority stake in STADA Arzneimittel AG to CapVest Partners. Bain and Cinven intended to retain a minority stake after completion. The release expected completion in the first half of 2026 and did not establish a closing date.

Majority stake in STADA Arzneimittel AG · RIA Monitor